Brainomix Showcases Growing Evidence for its Novel AI-Based Imaging Biomarkers in Lung Fibrosis

Brainomix Illinois California United Kingdom England

The company unveiled a series of new studies highlighting the prognostic value of its imaging biomarkers in patients with fibrotic lung diseaseThe studies reflect the company's expanding Life Science partnerships and academic collaborations with luminary research centers in the lung spaceView original content:https://www.prnewswire.co.uk/news-releases/brainomix-showcases-growing-evidence-for-its-novel-ai-based-imaging-biomarkers-in-lung-fibrosis-302152575.html